Pure Global

LUMAKRAS 120 MG FILM COATED TABLET, 240 PCS - Turkey License 373a2ae9c042afaaabd5ad9a4b1e1c87

Access comprehensive regulatory information for LUMAKRAS 120 MG FILM COATED TABLET, 240 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 373a2ae9c042afaaabd5ad9a4b1e1c87 with license number 2022/620and contains active ingredient Sotorasib . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
373a2ae9c042afaaabd5ad9a4b1e1c87
License Details
Turkey SFDA License: 373a2ae9c042afaaabd5ad9a4b1e1c87
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

LUMAKRAS 120 MG FILM COATED TABLET, 240 PCS
TR: LUMAKRAS 120 MG FİLM KAPLI TABLET, 240 ADET
Pharmaceutical Product

License Details

373a2ae9c042afaaabd5ad9a4b1e1c87

2022/620

8699862090131

L01XX73

License Holder Information

Active Ingredient

Sotorasib

License Information

Oct 28, 2022